Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of UNCY will rise by +0.52% over the next 2 Weeks and hit $5.06 by Tuesday, September 22, 2026. In that time frame, UNCY's share price is expected to range between $4.78 and $5.33.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 22, 2026 | 4.78 | 5.06 | 5.33 |
| Sep 21, 2026 | 4.72 | 4.99 | 5.27 |
| Sep 18, 2026 | 4.75 | 5.06 | 5.35 |
| Sep 17, 2026 | 4.85 | 5.12 | 5.40 |
| Sep 16, 2026 | 4.79 | 5.07 | 5.35 |
| Sep 15, 2026 | 4.77 | 5.04 | 5.32 |
| Sep 14, 2026 | 4.71 | 4.98 | 5.27 |
| Sep 11, 2026 | 4.77 | 5.04 | 5.32 |
| Sep 10, 2026 | 4.84 | 5.10 | 5.40 |
| Sep 9, 2026 | 4.76 | 5.06 | 5.35 |
UNCY shares rose +1.79% in Wednesday, September 9, 2026's trading session, rising from a previous close of $5.03 to move at $5.12. The stock demonstrated notable intraday movement (see UNCY's key stats for a full breakdown), fluctuating between $5.01 and $5.14, a +2.70% trading range. While recent weeks have seen some volatility, UNCY has managed to secure a -5.71% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 906.96K shares changing hands, 122.31K more than the previous session. This amounted to $4.64M in total market activity.
Will UNCY Continue Its Upward Trend?
According to analyst ratings and projections for UNCY, Unicycive Therapeutics, Inc. shares are anticipated to increase by +3.92%, potentially reaching $5.33 per share by September 22, 2026. Short-term technical indicators currently suggest a neutral sentiment for UNCY. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the UNCY stock forecast, now is a good time to buy UNCY stock because its current trading price is +1.26% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on UNCY covering social and institutional perspectives.
UNCY Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into UNCY's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.28% to 44.75%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.99%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.78%, maintains a neutral outlook for the long term. Insights into UNCY's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Unicycive Therapeutics Short-Term Forecasts
UNCY Forecast For Next 5 Days
Our algorithm anticipates Unicycive Therapeutics (UNCY) stock could hit $5.81 by Sep 16, 2026. This represents a +13.41% rise from today's price, following a +12.10% change over the past five days.
UNCY Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Unicycive Therapeutics, Inc. (UNCY) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $5.21, which would mean a +1.76% increase from the current price of $5.12. Projections for this period range from a high of $6.80 to a low of $3.51.
UNCY Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Unicycive Therapeutics's price over the next three months point to a rise. UNCY stock is expected to peak at $13.98 on Dec 07, 2026 after potentially dipping to $8.39 on Nov 03, 2026. On average, UNCY is likely to trade around $10.56 in the coming 90 days.
Unicycive Therapeutics Stock Forecast 2025
Based on our predictive models, Unicycive Therapeutics (UNCY) is expected to trade between $8.39 and $14.49 throughout 2026. This would result in an average price of $11.14, potentially offering investors a +117.58% return from current levels.
Unicycive Therapeutics, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Unicycive Therapeutics, Inc. (UNCY) is positioned to show a strong performance in September 2026. The price is predicted to move between $9.10 and $10.89, settling at an average of $10.24. This could translate to a +100.00% gain.
October 2026
Based on current market signals, Unicycive Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $8.45 to $10.98, with a likely average price of $9.48. Investors could expect a potential return of +85.16%.
November 2026
Our predictive algorithms indicate Unicycive Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $8.39–$13.24, with an average target of $11.08. This represents a positive outlook and a possible gain of +116.41%.
December 2026
Analyzing established trends, Unicycive Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $12.01 and $14.49, averaging around $13.42. This suggests a +162.11% gain from current levels.
January 2027
Market indicators suggest Unicycive Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $12.62 to $16.88, with a midpoint forecast of $15.53. The stock might deliver a +203.32% gain.
February 2027
Forecasting for February 2027, models estimate that Unicycive Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $12.22 and $19.70, averaging $16.74. This signals a positive trajectory with potential returns around +226.95%.
March 2027
According to our latest forecast models, Unicycive Therapeutics, Inc. (UNCY) is positioned to show a strong performance in March 2027. The price is predicted to move between $8.96 and $17.26, settling at an average of $14.22. This could translate to a +177.73% gain.
April 2027
Based on current market signals, Unicycive Therapeutics, Inc. is projected to trend april 2027. We forecast a trading range from $9.58 to $19.64, with a likely average price of $15.57. Investors could expect a potential return of +204.10%.
May 2027
Our predictive algorithms indicate Unicycive Therapeutics, Inc. stock may see a shift in May 2027. The expected range spans $8.15–$21.82, with an average target of $17.07. This represents a positive outlook and a possible gain of +233.40%.
June 2027
Analyzing established trends, Unicycive Therapeutics, Inc. looks set to move in June 2027. Projections place the stock between $6.71 and $23.61, averaging around $17.10. This suggests a +233.98% gain from current levels.
July 2027
Market indicators suggest Unicycive Therapeutics, Inc. could experience notable changes during July 2027. Prices could fluctuate within $3.83 to $21.26, with a midpoint forecast of $14.33. The stock might deliver a +179.88% gain.
August 2027
Forecasting for August 2027, models estimate that Unicycive Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.35 and $16.28, averaging $9.53. This signals a positive trajectory with potential returns around +86.13%.
September 2027
According to our latest forecast models, Unicycive Therapeutics, Inc. (UNCY) is positioned to show a strong performance in September 2027. The price is predicted to move between $2.73 and $17.18, settling at an average of $11.04. This could translate to a +115.62% gain.
UNCY's history of dividends and stock splits also plays a role in long-term investor confidence.